Health and Wellness
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.
The company offers a marketplace for individuals seeking addiction and mental health treatment. It will use the funds to scale its workforce and expand its reach.
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
The funds will be used to scale partnerships with health plans, employers and community-based public health agencies across the country.
Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi's platform.
The partnership will facilitate same-day screening for people with Alzheimer's and other dementias.
ProPhet's aim is to bring down the time and cost of finding molecules for new drug targets.
The ISS National Lab and MicroQuin joined forces to analyze and pinpoint changes in cancer cells.